Abstract
This study determined the effect of hepatitis B virus (HBV) replication in peripheral blood mononuclear cell (PBMC) from HBsAg-positive mothers on HBV intrauterine transmission. A total of 150 HBsAg-positive mothers and their neonates were recruited in this study. Within 24 h after birth, HBV serological markers, serum HBV DNA, PBMC HBV relaxed circular DNA (rcDNA), and covalently closed circular DNA (cccDNA) were measured in the HBsAg-positive mothers and their neonates before passive-active immune prophylaxis. The relationship between HBV replication in PBMC and HBV intrauterine transmission was examined through Chisquare test and logistic regression. The rate of HBV intrauterine transmission was 8.00% (12/150) in the 150 neonates born to HBsAg-positive mothers. The positivities of PBMC HBV rcDNA and cccDNA in the HBsAg-positive mothers were 36.67% (55/150) and 10% (15/150), respectively. Maternal PBMC HBV cccDNA was a risk factor of HBV intrauterine transmission (OR = 6.003, 95% CI: 1.249–28.855). Maternal serum HBeAg was a risk factor of PBMC HBV rcDNA (OR = 3.896, 95% CI: 1.929–7.876) and PBMC HBV cccDNA (OR = 3.74, 95% CI: 1.186–11.793) in the HBsAg-positive mothers. Administration of hepatitis B immune globulin was a protective factor of PBMC HBV cccDNA (OR = 0.312, 95%CI: 0.102–0.954) during pregnancy. The positivity of PBMC HBV rcDNA was related to that of cccDNA in the HBsAg-positive mothers (χ2= 5.087, P = 0.024). This study suggests that PBMC is a reservoir of HBV and an extrahepatic site for virus replication and plays a critical role in HBV intrauterine transmission.
Similar content being viewed by others
References
Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012; 30(12): 2212–2219
Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014; 384(9959): 2053–2063
Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012; 32(4): 612–621
Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with postantiviral treatment results. Clin Res Hepatol Gastroenterol 2013; 37(2): 152–158
Xu YY, Liu HH, Zhong YW, Liu C, Wang Y, Jia LL, Qiao F, Li XX, Zhang CF, Li SL, Li P, Song HB, Li Q. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus. Int J Biol Sci 2015; 11(3): 266–273
Bai GQ, Li SH, Yue YF, Shi L. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection. Arch Gynecol Obstet 2011; 283(2): 317–321
Cabrerizo M, Bartolomé J, Caramelo C, Barril G, Carreño V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000; 32(1): 116–123
Shi XH, Wang SP, Li SZ, Xie LJ, Feng LP, Shuang JY. Study on replication status of HBsAg positive pregnant women and newborns. Chin J Publ Health (Zhongguo Gong GongWei Sheng) 2004; 20(5): 513–514 (in Chinese)
Nassal M. HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 2015; 64(12): 1972–1984
Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol 2016; 64(1 Suppl): S4–S16
Cai D, Wang X, Yan R, Mao R, Liu Y, Ji C, Cuconati A, Guo H. Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators. Antiviral Res 2016; 132: 26–37
Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat 2012; 19(2): e18–e25
Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10(21): 3215–3217
Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV, Verma IM. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 2010; 120(3): 924–930
Coffin CS, Mulrooney-Cousins PM, Peters MG, van Marle G, Roberts JP, Michalak TI, Terrault NA. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepat 2011; 18(6): 415–423
Brind A, Jiang J, Samuel D, Gigou M, Feray C, Bréchot C, Kremsdorf D. Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. J Hepatol 1997; 26(2): 228–235
Stoll-Becker S, Repp R, Glebe D, Schaefer S, Kreuder J, Kann M, Lampert F, Gerlich WH. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol 1997; 71(7): 5399–5407
Zhang YL, Xu D, Wu XX, Wu J, Shao XY, Chen H, Zhang Q. HBVcccDNA of patients with hepatitis B in the serum, PBMC and liver tissue distribution. Chin J Exp Clin Virol (Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi) 2008; 22(5): 342–344 (in Chinese)
Shao Q, Zhao X, Yao Li MD. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection. Arch Gynecol Obstet 2013; 288(6): 1257–1261
Guo Z, Shi XH, Feng YL, Wang B, Feng LP, Wang SP, Zhang YW. Risk factors of HBV intrauterine transmission among HBsAgpositive pregnant women. J Viral Hepat 2013; 20(5): 317–321
Xu DZ, Yan YP, Choi BCK, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67(1): 20–26
Yu MM, Gu XJ, Xia Y, Wang GJ, Kan NY, Jiang HX, Wu KH, Ji Y, Ju LL. Relationship between HBV cccDNA expression in the human ovary and vertical transmission of HBV. Epidemiol Infect 2012; 140(8): 1454–1460
Wang XJ, Wang SP, Li TG, Feng YL. The status of HBV infection in peripheral blood mononuclear cells from 114 HBsAg-positive mothers and their newborns. J Guangdong Med Coll (Guangdong Yi Xue Yuan Xue Bao) 2006; 24(2): 131–133 (in Chinese)
Wei JN, Wang SP, Shuang JY. Study on the relationship between fetomaternal cellular traffic and hepatitis B virus intrauterine infection. Chin J Epidemiol (Zhonghua Liu Xing Bing Xue Za Zhi) 2005; 26(4): 240–244 (in Chinese)
Zhu Q, Yu G, Yu H, Lu Q, Gu X, Dong Z, Zhang X. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J (Engl) 2003; 116(5): 685–687
Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, Yao J, Dong H, Jiang M. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13(9): 597–604
Li F, Cheng L, Murphy CM, Reszka-Blanco NJ, Wu Y, Chi L, Hu J, Su L. Minicircle HBV cccDNA with a Gaussia luciferase reporter for investigating HBV cccDNA biology and developing cccDNAtargeting drugs. Sci Rep 2016; 6(1): 36483
Kennedy EM, Kornepati AV, Cullen BR. Targeting hepatitis B virus cccDNA using CRISPR/Cas9. Antiviral Res 2015; 123: 188–192
Dong C, Qu L, Wang H, Wei L, Dong Y, Xiong S. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication. Antiviral Res 2015; 118: 110–117
Acknowledgements
This study was supported by the National Natural Science Foundation of China (Nos. 30070669 and 81573212).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shi, X., Wang, X., Xu, X. et al. Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission. Front. Med. 11, 548–553 (2017). https://doi.org/10.1007/s11684-017-0597-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-017-0597-5